Active, not recruitingPhase 1NCT05421897

Rapid Administration Pilot for Infusing Dinutuximab

Studying Neuroblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Los Angeles
Principal Investigator
Sara-Jane Onyeama, MD
Children's Hospital Los Angeles
Intervention
Dinutuximab with Chemotherapy(drug)
Enrollment
11 target
Eligibility
1 years · All sexes
Timeline
2022 – 2026

Study locations (1)

Collaborators

United Therapeutics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05421897 on ClinicalTrials.gov

Other trials for Neuroblastoma

Additional recruiting or active studies for the same condition.

See all trials for Neuroblastoma →

← Back to all trials